Michael E Ransom Burczynski

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Although biomarkers have been the essence of laboratory medicine since its inception, they are relatively new tools in the development of pharmaceutical compounds. The main utility of biomarkers for pharmaceutical companies has been in making drug development a more efficient and a cost-effective process. This is primarily the case because of the drastic(More)
  • 1